An international research team has uncovered a new mechanism crucial to the production of cellular proteins. When this ...

The Korea Research Institute of Standards and Science (KRISS) announced that they have developed an advanced disease ...

AlloVir has entered into a definitive agreement for the acquisition of the complete outstanding shares of Kalaris ...

The genetic testing rate is lower for Black than non-Hispanic White patients with inherited retinal diseases (IRDs), ...

Sandoz's approval of Afqlir highlights their commitment to affordable, effective treatment options for retinal diseases.

Sandoz remains committed to accelerating patient access by strengthening its biosimilar portfolio, reinforcing global and European leadership ...

Researchers from Peking University have introduced a novel deep learning-based method for noninvasive choroidal vessel ...

Afqlir is indicated to treat various retinal diseases, including neovascular age-related macular degeneration (nAMD) ...

An RNA-editing gene therapy has been developed that switches off the key driver of common eye conditions affecting diabetics ...